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Abstract
Introduction: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role
of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM)
environment to this phenomenon, we isolated ECM surrogate invading cell populations from MDA-MB-231 breast cancer
cells and studied their genotype and malignant phenotype.
Methods: We isolated invasive subpopulations (INV) from non invasive populations (REF) using a 2D-Matrigel assay, a
surrogate of basal membrane passage. INV and REF populations were investigated by microarray assay and for their
capacities to adhere, invade and transmigrate in vitro, and to form metastases in nude mice.
Results: REF and INV subpopulations were stable in culture and present different transcriptome profiles. INV cells were
characterized by reduced expression of cell adhesion and cell-cell junction genes (44% of down regulated genes) and by a
gain in expression of anti-apoptotic and pro-angiogenic gene sets. In line with this observation, in vitro INV cells showed
reduced adhesion and increased motility through endothelial monolayers and fibronectin. When injected into the
circulation, INV cells induced metastases formation, and reduced injected mice survival by up to 80% as compared to REF
cells. In nude mice, INV xenografts grew rapidly inducing vessel formation and displaying resistance to apoptosis.
Conclusion: Our findings reveal that the in vitro ECM microenvironment per se was sufficient to select for tumor cells with a
stable metastatic phenotype in vivo characterized by loss of adhesion molecules expression and induction of pro-
angiogenic and survival factors.
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Introduction
Metastasis in breast cancer patients accounts for over 90% of
the deaths. Preclinical studies reveal that many drugs used in the
management of primary tumors are not or less effective against
metastasis [1]. Although the mechanism by which metastases
develop is still not fully understood, it is generally believed that
tumor cells acquire features that affect their metastatic potential
during the progression of the tumor; these features include
increased survival, invasive and migratory abilities. Metastasis is a
complex cascade of sequential steps, none of which being fully
understood. Many studies implicated the stroma in the develop-
ment of metastases. Stroma and cancer cell interactions were
found to contribute to cell detachment from primary tumors,
intravasation into the blood stream, and extravasation at distant
sites where tumor cells can seed and form tumor metastases [2].
Previously, fibroblasts, endothelial cells and macrophages and
other stroma cells were reported to be implicated in the
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23334occurrence of metastases [2–4]. Whereas less is known about the
influence of the extracellular matrix (ECM) in the development of
metastases [5,2], ECM appears to be involved, particularly
through sequestration of soluble factors secreted by stroma cells
and acting on tumor cells in a paracrine manner [6–9]. The ECM
can modify the adhesion of cancer cells leading to their invasive
behavior. However, it is not clear if the ECM, and particularly the
basement membrane, can influence the selection of metastatic cells
with a well-defined genotype profile. The basement membrane
underlies the endothelium in the vessel wall and is the major
barrier to tumor cell extravasation and invasion [10–11]. Matrigel
is a basement membrane extract derived from a murine tumor
[12]. The components of this tumor basement membrane are
similar, both chemically and immunogically, to authentic
basement membrane components [13]. Consequently, Matrigel
may be used as an experimental model of barrier to identify both
inhibitors and activators of invasion [14].
Most of previously reported studies on gene profiling in
malignant cells used tumor cells isolated from metastatic foci that
were already well established in vivo. Therefore, the contribution of
ECM to the selection of metastatic cells has not been rigorously
assessed. Here, we report the in vitro selection of two cell
populations derived from MDA-MB-231 breast cancer cells [15],
on the basis of their high (INV) invasive ability (to migrate through
Matrigel). We examined the transcriptomes of these two
populations using micro arrays and correlated their gene profiles
to their malignant phenotypes.
Materials and Methods
Cell culture
Human breast adenocarcinoma MDA-MB-231 cells were
obtained from the American Type Culture Collection (Manassas,
VA, USA). The INV and REF cells isolated as described
underneath were maintained in 10% FBS-DMEM, 1% sodium
pyruvate with 1% penicillin and 1% streptomycin at 37uCi na
humidified atmosphere containing 5% carbon dioxide. Human
microcapillary brain endothelial hCMEC/D3 cells [16,17] were
grown in collagen type I-coated dishes in EBM-2 media
supplemented with 2.5% FBS, hydrocortisone and growth factors
(VEGF, IGF, EGF and bFGF EGM-2 Bullet kit, Cambrex-
Biowhittaker).
Isolation of MDA-MB-231 derived INV and REF variants
MDA-MB-231 cells (2.5610
5) were seeded in 8 mm-pore size
Boyden chambers (Becton Dickinson) coated with Matrigel
(Falcon, MA, USA) and incubated for 16 h at 37uCi na5 %
CO2 atmosphere. Invading cells, referred to as INV cells, were
collected from the bottom of the membrane in 0.5 mM EDTA
and cultured in a 24-well plate. The selection was repeated eight
times sequentially in order to obtain highly invasive cells. To select
non-invasive cells (REF), the same procedure was used and the
cells that remained on top of the membrane after the first round of
selection were collected.
Cell growth, migration and invasion assay
For cell growth assays, INV and REF cells were seeded at
2610
5 cells per well in 6-well plates and cultured for 72 h. Cell
migration experiments were performed using the Boyden
chambers as described above: the cells (2.5610
5) were put into
the upper chamber and 10% FCS-DMEM was used as a
chemoattractant. For invasion assays, chambers were coated with
Matrigel as described above. Then, cells on the lower face of the
filter were fixed, stained with crystal violet and counted under the
optical microscope.
Adhesion and transmigration assays
Tumor cells were harvested in 0.5 mM EDTA and seeded at
5610
5 cells per well in 96-well plates pre-coated with 1 mg/ml of
fibronectin (Sigma, France) and incubated at 37uC for 1 h. The
plates were washed with PBS, and adherent cells were stained with
crystal violet/methanol (0.5%/20%) for 1 h at room temperature.
The plates were again washed, and were incubated in ethanol:
0.1 M citrate (1:1) pH 4.2 for 30 min at room temperature and
absorbance was measured at 540 nm using an ELISA reader
(Labsystem, GMI Inc, Minnesota, USA). To study tumor cell
adhesion to endothelial cell monolayers, hCMEC/D3 cells were
seeded at 10
4 cells per well on collagen type I-coated 96-wells
plates and left to grow until confluence. The cells were then
starved for 48 h and incubated for an additional 24 h with the
proinflammatory cytokines IFNc (100 U/ml-Preprotech Inc, NJ,
USA.) and TNFa ´ (200 U/ml-Preprotech Inc.). Next, the INV and
REF cells at 80% confluence were harvested using PBS-EDTA
and labeled for 30 min at 37uC with CMFDA, a green fluorescent
cell tracker (Invitrogen, Cergy Pontoise, France). Then, 10
5 INV
or REV cells were added to the endothelial cell monolayer and
incubated for 30 min at 37uC. The unattached cells were removed
and adherent cells were lysed with water. Fluorescence was
measured at 485/530 nm using a microplate reader (Labsystem,
France). For transmigration assays, Boyden chambers were coated
with hCMEC/D3 endothelial cells and CMFDA-labeled tumor
cells were counted by fluorescent microscopy.
Gelatine zymography
INV and REF cells were cultured in serum-free media for 24 h
in 6-well plates. Conditioned media were then lyophilized and
normalized to the number of cells. They were mixed with non-
reducing Laemmli buffer and run on a 10% SDS-polyacrylamide
gel containing 1 mg/ml gelatin. The gel was washed three times at
room temperature in a solution containing 2.5% (v/v) Triton X-
100 and incubated at 37uC for 24 h in 50 mM Tris/HCL,
pH 7.5, 0.2 M NaCl, 5 mM CaCl2 and 0.05% Brij 35. The gel
was then stained for 60 min with 0.25% (w/v) R-250 Coomassie
blue in 45% (v/v) methanol/10% (v/v) acetic acid and destained
in 25% methanol (v/v)/10% acetic acid (v/v).
Cell death detection
Cells (2610
5) were cultured for 96 h in a serum-free medium or
with 2.5 mM Doxorubicin for 24 h in a serum-containing medium.
Then, cells were harvested and apoptotic cells were labeled using
the Annexin V-FITC Apoptosis Detection kit (Beckman coulter,
Fullerton CA, USA). The samples were then analyzed by flow
cytometry (Becton Dickinson, Heidelberg, Germany). For detec-
tion of cell death in vivo, tumor sections (5 mm) were deparaffinized
and rehydrated, then analyzed for DNA fragmentation using a
TumorTACS kit (R&D Systems, Abington, UK). Various fields
(10 per section) were selected for analysis and the intratumor apo-
necrotic cells were counted as previously described [18]. For AKT
phosphorylation assay, cells were treated for 1 h or 72 h with
serum free medium and stimulation with IGF-1 at 10 ng/ml for
30 min was used as positive control.
Western blots
INV and REF cell lysates were clarified by centrifugation, and
protein concentrations were measured by bicinchoninic acid
protein assay (Bio-Rad, Marne-La-Coquette, France). Equal
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transferred to nitrocellulose membrane. The membrane was
blocked in 5% nonfat dried milk in Tris-buffered saline containing
1% Tween 20 and incubated with primary antibodies against
NRP-1 (Santa-Cruz Biotechnologies inc., CA) or ß-actin (Sigma,
Saint quentin Fallavier, France), AKT or pAKT (Cell signaling
technology, Boston, USA) for 1 h, and then with an appropriate
conjugated secondary antibody for 30 min at room temperature.
Immunoreactive bands were detected by chemiluminescence
according to the manufacturer’s instructions.
VEGF quantification
INV or REF cells seeded in 24-well culture plates (2610
5/well)
in DMEM–10% FCS were allowed to adhere for 24 h.
Conditioned media containing growth factors secreted by the
cells were collected after 48 h of serum starvation. The VEGF
content in these media was measured by quantitative enzyme-
linked immunoabsorbent sandwich assay (ELISA) using the
Quantikine kit (R&D Systems, Abington, UK) according to the
manufacturer’s instructions. VEGF contents were estimated from
a standard curve established from serial dilutions of VEGF protein
standards (R&D Systems). The values reported for VEGF
secretion are normalized to cell number.
Real-time RT-PCR analysis
Total RNA (1 mg) was reverse-transcribed using MMLV RT
(Invitogen, Carlsbad, CA, USA) and random primers from Roche
Applied Science (Roche, Indianapolis, IN, USA). Primers for
qRT-PCR were purchased from AnyGenes (Creteil, France).
Real-time PCR was carried out with the LightCyclerH 2.0 Real-
Time PCR System (Roche, Indianapolis, IN, USA) using the
LightCyclerH FastStart DNA Master
PLUS SYBR Green I Kit. The
reactions were cycled 45 times [95uC, 10 min, (94uC, 15 sec;
60uC, 1 min; and 72uC, 1 min)]. Reported results are normalized
to the expression of the PPIA, GAPDH, TBP, beta 2 Microglobin,
Actin, RPL0 and RPL19 genes that exhibit little variation in this
data set. Similar results were obtained for all reference genes, the
representative data is normalized to PPIA. Fold induction relative
to internal controls was calculated by the delta Ct evaluation
method [19].
Gene Expression Profiling
Total RNA was isolated from eight cell cultures (four biological
replicates corresponding to four different passages of both INV
and REF cells) using the RNeasy mini kit (Qiagen, Valencia, CA,
Germany) by direct cell lysis in 10 cm culture dishes containing
600 ml RLT Buffer following the manufacturer’s instructions.
Purified RNA was quantified with a Nanodrop ND-1000
spectrophotometer (Thermo Fisher Scientific, Hudson, NH,
USA) and its quality was evaluated by running the Eukaryotic
Total RNA Nano Assay in the Bioanalyser 2100 (Agilent
Technologies, Chandler AZ, USA) using the Agilent RNA 6000
Nano Kit. Probes (300 ng of the total RNAs) were prepared for
hybridization to Affymetrix GeneChipH Human Gene 1.0 ST
arrays according to the manufacturer’s instructions. After
scanning, eight CEL files generated by GCOS (Affymetrix
GeneChipH Operating Software) were uploaded into Expression
Console Software (Affymetrix, Santa Clara, CA, USA) for
normalization and probe set summarization using the RMA
(Robust Multichip Analysis) algorithm [20]. The resulting data in
terms of probe set intensities were exported into a .txt file for
further statistical analysis. The microarray data has been deposited
in the Gene Expression Omnibus (GEO) database at http://www.
ncbi.nlm.nih.gov/geo/ with the accession number GSE16838.
Microarray data analysis
Analyses were carried out in R, a free software environment
available at http://www.r.-project.org/. To identify differentially
expressed genes, differences between the two conditions were
calculated on each day of measurement and then analyzed using a
double-sided paired t-test implemented in the anapuce R package
(http://www.agroparistech.fr/mia/outil.html). Pairing was carried
out to remove any source of variation due to the day of
measurement from the comparison of the two conditions. The
variance was split between subgroups of genes with homogeneous
variance [21]. Statistical raw p-values were adjusted for multiple
comparisons using the Benjamini-Hochberg procedure [22] which
controls the False Discovery Rate (FDR) after the estimation of the
proportion of genes non-differentially expressed using the
smoother method [23]. The level of statistical significance was
set at 0.05 for all comparisons. Gene annotations and functions
were assessed using NetAffx
TM Analysis Center (Affymetrix, Santa
Clara, CA, USA), Ingenuity pathway Analysis (IPA) software
(Ingenuity SystemsInC.) and data mining.
Xenografts in nude mice
All in vivo experiments were carried out with the approval of
De ´partement d’Expe ´rimentation Animale, Institut Universitaire
d’He ´matologie, Ho ˆpital Saint-Louis ethical committee (permit
number 75516) and according to the UKCCCR guidelines. The
animals were kept in a temperature-controlled room on a 12: 12
light-dark schedule with food and water ad libidum. Aliquots of
2610
6 of INV (n=7) or REF cells (n=7) were inoculated
subcutaneously (s.c) near the mammary gland of 4-week-old
athymic nude mice (nu/nu, Janvier, France, n=14). Tumor
volume was measured once a week along two major axes using
calipers. Tumor volume (mm
3) was calculated as follows: V=
4/3pR1
2R2 where R1,R2
Immunohistochemical analysis
Tumor specimens were fixed with 4% paraformaldehyde and
embedded in paraffin using standard procedures. For immuno-
histochemical studies, 5 mm-thick sections were cut, deparaffinized
and rehydrated. Routinely, sections were stained in haematoxylin
and eosin. Endogenous peroxidase was inactivated with 3% H2O2
and washed in TBS (0.05 M Tris, 1.5 M NaCl, pH 7.6) followed
by preincubation in 10% normal goat serum for 1 h at room
temperature. Endothelial cells were specifically labeled with GSL-
1 isolectin B4 (Vector Laboratories, Burlingame, CA, U.S.A.) as
described previously [24]. For each tumor, 10 randomly selected
sections were analyzed.
Intracardiac experimental metastasis assay
We performed mice intracardiac injection of bioluminescent
INV and REF cells as also described previously in order to
observe large dissemination behavior of each subpopulation [25].
For this study, luciferase-expressing INV and REF cell pools were
obtained by stable transfection with a plasmid carrying a G418
resistance gene and the luciferase gene (pEGFPLuc, BD
Biosciences, Rungis, France) using Fugen-6 (Roche Diagnostics,
Meylan, France). Transfected cells were cultured in 10% FCS-
DMEM supplemented with G418 at 1 mg/ml. For experimental
metastasis, female nude mice (8–10 weeks) were anesthetized by
intraperitoneal injection with 120 mg/kg ketamine and 6 mg/kg
xylazine on the day of cell injection or by exposure to 1–3%
isoflurane on subsequent imaging days. pEGFPLuc-transfected
INV or REF cells (10
5) in 100 ml of sterile DPBS were injected
into the left ventricle of the heart by nonsurgical means.
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luciferin (Caliper Life Science) and placed in the IVIS
TM Imaging
System (Xenogen, Caliper Life Science, MA, USA) and imaged
from both dorsal and ventral views. Successful intracardiac
injection was revealed on day 0 by systemic bioluminescence
distributed throughout the whole animal. Only mice with
satisfactory injection were used for subsequent experiments.
Metastasis analysis was monitored by in vivo imaging once a week
for up to eight weeks.
Bioluminescent Imaging
Bioluminescence images were acquired with the IVIS imaging
system (Xenogen) 5 minutes after intraperitoneal injection of D-
luciferin into the anesthetized animals. Acquisition time at the
beginning of experiment was 5 min and was reduced in keeping
with signal strength to avoid saturation. Analysis was performed
using LivinImage software (Xenogen) by measurement of photon
flux (photon/s/cm
2) within a region of interest (ROI) drawn
around the bioluminescence signal to detect the metastatic sites.
Figure 1. INV and REF breast cancer cell invasion and migration. Cells (2.5610
5) were added to the upper side of each 8 mm insert of Boyden
chambers coated (A) or not (B) with Matrigel for invasion or migration assays respectively; cells were then counted as described in Materials and
Methods. MMP-9 activity secreted by REF (lane 1) and INV (lane 2) cells (C) was assessed by subjecting aliquots of lyophilized conditioned media
normalized to the number of cells to 10% SDS-polyacrylamide gels containing 1 mg/mL gelatin. For QRT-PCR analysis (D), total RNA (1 mg) was
reverse-transcribed using MMLV RT and subjected to qRT-PCR as described in Material and Methods. Representative data was normalised to PPIA is
given. Each column represents a mean (6 SD) of three independent experiments. *P,0.05.
doi:10.1371/journal.pone.0023334.g001
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Student’s t-test was used for statistical analysis. P,0.05 was
considered significant.
Results
Selection of INV subpopulation from MDA-MB-231
Using Matrigel coated Boyden chambers, we established two
different sub-populations of MDA-MB-231 cells. These included
the invasive MDA-MB-231 subpopulation (INV) that was isolated
from a less invasive subpopulation (REF) following eight rounds of
invasion assays in the Boyden Chamber. Their invasive phenotype
was confirmed by migration and invasion assays (Fig. 1). REF cells
were expanded and frozen after the first round. As expected, INV
cells were up to 4-fold more invasive than REF cells (Fig. 1A and
right panel), and up to 3-fold more motile (Fig. 1B and right
panel). These properties were stable and not lost after mainte-
nance in culture or freezing. To assess the invasive capacity of INV
and REF cells in more detail, the corresponding conditioned
media were collected and analyzed for gelatinase enzymatic
activity (Fig. 1C). MMP-9 activity was higher in media
conditioned by INV cells as compared to REF cells. In contrast,
MMP-2 activity remained unchanged (data not shown). Similarly,
the mRNA expression of uPA, uPAR and PAI-1 were found
significantly up-regulated in INV cells as evaluated by real time
PCR (Fig. 1D).
Transcriptomic analysis of INV and REF cells
We used the Affymetrix Human Gene 1.0ST arrays that
contain 28000 annotated genes (Table 1 and 2), to investigate the
expression profile of REF and INV cells. Comparative analysis of
REF and INV cells revealed 134 differentially expressed genes
(Table S1): 38 were down-regulated and 96 were up-regulated in
INV cells with respect to REF cells. Among the known down-
regulated genes in INV cells (Table 1), 44% are involved in cell
adhesion and cell-cell junctions, and 22% in induction of apoptosis
and G-protein coupled receptor signaling (Fig. S1). Of the up-
regulated genes in INV (Table 2) with known function, 25% are
involved in survival via negative regulation of apoptosis, 17.5% in
cytoskeleton reorganization, cell proliferation and chemotaxis,
12.5% in cell adhesion and cell-cell junctions and 10% in G-
protein coupled receptor signaling (Fig. S1).
Table 1. List of genes that are down-regulated in INV cells versus REF cells.
Gene Symbol Gene Title Description log fold Adjusted p-value
CCND2* cyclin D2 cell cycle 22,25 0,039
FERMT3* fermitin family homolog 3 (Drosophila) cell adhesion 21,70 0,039
SYTL3 synaptotagmin-like 3 intracellular protein transport /// Rab
GTPase binding
21,61 0,021
GABRA3 gamma-aminobutyric acid (GABA)
A receptor, alpha 3
ion transport /// cell junction 21,38 0,022
ABI3 ABI gene family, member 3 regulation of cell migration 21,28 0,039
HMGCS1 3-hydroxy-3-methylglutaryl-Coenzyme
A synthase 1 (soluble)
isoprenoid biosynthetic process 21,16 0,046
OCLN occludin cell junction 21,12 0,040
GPR176 G protein-coupled receptor 176 G-protein coupled receptor protein
signaling pathway
21,07 0,040
AMIGO2 adhesion molecule with Ig-like
domain 2
cell adhesion /// negative regulation of
programmed cell death
21,03 0,046
GNGT2 guanine nucleotide binding protein
(G protein), gamma transducing
activity polypeptide 2
signal transduction /// G-protein coupled
receptor protein signaling pathway
20,99 0,039
ASAM adipocyte-specific adhesion molecule cell junction 20,97 0,042
HMGCR 3-hydroxy-3-methylglutaryl-Coenzyme
A reductase
isoprenoid biosynthetic process 20,93 0,050
SCARF1 scavenger receptor class F, member 1 cell adhesion 20,91 0,039
STAT5A signal transducer and activator of
transcription 5A
transcription factor activity /// positive regulation
of cell proliferation /// regulation of cell adhesion
/// regulation of epithelial cell differentiation ///
negative regulation of apoptosis /// positive
regulation of survival gene product expression
/// positive regulation of mitotic cell cycle ///
positive regulation of inflammatory response
20,81 0,047
CASP4* caspase 4 induction of apoptosis 20,79 0,046
PCDHB2 protocadherin beta 2 cell adhesion 20,74 0,040
CARD6 caspase recruitment domain family,
member 6
regulation of apoptosis 20,73 0,043
TP53BP1 tumor protein p53 binding protein 1 DNA repair /// transcription activator activity 20,72 0,046
Genes’ functions are based on GO Description provided by Affymetrix, NetAffx data base (https://www.affymetrix.com/analysis/netaffx/index.affx).
*Validated by QRT-PC.
doi:10.1371/journal.pone.0023334.t001
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Gene Symbol Gene Title Description log fold Adjusted p-value
MID2 midline 2 cytoskeleton /// microtubule associated complex 0,58 0,049
PLP2 proteolipid protein 2
(colonic epithelium-
enriched)
chemotaxis 0,61 0,048
TGFB2* transforming growth
factor, beta 2
angiogenesis /// epithelial to mesenchymal transition /// cell growth
/// extracellular matrix organization and biogenesis /// regulation of
apoptosis /// positive regulation of cell cycle /// somatic stem cell
division /// negative regulation of epithelial cell proliferation ///
regulation of immune response
0,62 0,048
CETN2 centrin, EF-hand protein, 2 cell cycle /// mitosis /// cell division 0,64 0,046
TMSB4X ///
TMSL1,2,3,6
thymosin beta 4, X-linked
/// thymosin-like 1,2,3 and
6 (pseudogenes)
cytoskeleton organization and biogenesis 0,64 0,046
GPR17 G protein-coupled
receptor 17
chemokine receptor activity /// G-protein coupled receptor protein
signaling pathway
0,65 0,042
L1CAM* L1 cell adhesion
molecule
cell adhesion /// cell differentiation 0,66 0,046
GDI1 GDP dissociation
inhibitor 1
Rab GDP-dissociation inhibitor activity /// small GTPase mediated
signal transduction
0,69 0,045
MAGED1 melanoma antigen
family D, 1
transcription coactivator activity /// regulation of apoptosis ///
negative regulation of epithelial cell proliferation
0,70 0,048
RBBP7* retinoblastoma binding
protein 7
cell proliferation 0,70 0,042
CD99L2 CD99 molecule-like 2 cell adhesion /// cell junction 0,71 0,040
ATP6AP2 ATPase, H+ transporting,
lysosomal accessory
protein 2
angiotensin maturation /// receptor activity /// positive regulation
of transforming growth factor-beta1 production /// regulation of
MAPKKK cascade
0,73 0,040
FANCB Fanconi anemia,
complementation
group B
DNA repair 0,73 0,040
IRAK1* interleukin-1 receptor-
associated kinase 1
signal transduction /// transmembrane receptor protein serine/
threonine kinase signaling pathway /// activation of NF-kappaB-
inducing kinase activity /// transcription activator activity ///
interleukin-1 receptor complex
0,73 0,042
SUV39H1 suppressor of
variegation 3–9
homolog 1 (Drosophila)
cell cycle /// cell differentiation 0,73 0,040
BCAP31 B-cell receptor-
associated protein 31
apoptosis /// immune response 0,74 0,040
FGD1 FYVE, RhoGEF and PH
domain containing 1
cytoskeleton organization and biogenesis /// signal transduction
/// regulation of cell shape /// small GTPase binding /// regulation
of Rho protein signal transduction
0,74 0,040
NKAP NFKB activating protein 0,75 0,040
RAB9A RAB9A, member RAS
oncogene family
small GTPase mediated signal transduction /// protein transport 0,77 0,040
CD99 CD99 molecule cell adhesion 0,77 0,042
ARAF v-raf murine sarcoma
3611 viral oncogene
homolog
protein serine/threonine kinase activity 0,78 0,040
AIFM1 apoptosis-inducing factor,
mitochondrion-associated, 1
DNA fragmentation during apoptosis /// apoptosis /// DNA damage
response, signal transduction resulting in induction of apoptosis
0,79 0,040
HCLS1 hematopoietic cell-specific
Lyn substrate 1
transcription factor activity /// positive regulation of cell proliferation
/// response to hormone stimulus /// positive regulation of tyrosine
phosphorylation of STAT protein
0,79 0,049
HDAC6 histone deacetylase 6 cell cycle /// specific transcriptional repressor activity 0,79 0,039
APEX2 APEX nuclease (apurinic/
apyrimidinic endonuclease) 2
DNA repair /// lyase activity 0,79 0,040
UXT ubiquitously-expressed
transcript
microtubule cytoskeleton organization and biogenesis 0,80 0,045
SLC25A6 solute carrier family 25,
member 6
mitochondrial transport /// apoptosis 0,83 0,039
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Adhesion and transmigration abilities of INV and REF
cells
The main differences between the transcriptome profiles of the
two cell populations concerned molecules involved in cell-ECM
and cell-cell junctions. Therefore, we tested INV and REF cells for
adhesion and transmigration through endothelial cells. As
observed in Fig. 2A, the morphology of INV cells in monolayer
cultures differed from that of REF cells. INV but not REF
monolayers cells seemed to present gaps between cells. In addition,
REF cells were round whereas INV cells were fusiform.
We next tested adhesion of INV and REF cells to fibronectin
and hCMEC/D3 brain microcapillary endothelial cells (Fig. 2 B
and C, respectively). Consistent with findings for the transcrip-
tomes, REF cells adhered to fibronectin whereas INV cells did not
(the optical density was the same as for negative controls,
equivalent to fold induction of 1) (Fig. 2B). Although both cell
populations adhered to the endothelium formed by hCMEC/D3
human brain microcapillary endothelial cells, INV cells again
showed a lower adhesion capacity than REF cells both in the
presence or absence of cytokines (Fig. 2C) (proinflammatory
cytokines have been reported to activate endothelial cells and
induce tumor cell attachment to the endothelium [26]).
Next, we compared the ability of INV and REF cells to
transmigrate through hCMEC/D3 endothelial cells (Fig. 2D):
INV cell transmigration was 1.5 fold higher than that of REF cells
(p,0.05).
Increased metastatic sites colonization and reduced
survival in INV cell-inoculated mice
In order to study the subclones metastasis behaviour in the
whole body, Luc-transfected subclones of INV and REF (1610
5)
were injected in the circulation (intracardiac route as described
previously, [25]) of nude mice (n=9) and their abilities to colonize
secondary sites were evaluated weekly during eight weeks (Fig. 3A).
Metastases were detected after two and three weeks in mice
injected with INV and REF cells, respectively. Five weeks after
injection, multiple metastatic sites were detected in mice
inoculated with INV cells (Fig. 3A and C). In general, in each
mouse inoculated with REF cells, one metastatic site was detected,
mainly in bone rather if only one mouse developed lung metastasis
which lead to rapid death at day 37 (data not shown. In addition,
ex vivo imaging of various tissues after the final in vivo imaging
mainly revealed the presence of lesions in bones for REF cells
injections (legs and skull) and brain, lymph nodes and ovary for
INV ones (Fig. 3B). Ovarian lesions were only found in INV cell-
injected mice (4 of 9 mice) and most smooth tissue lesions were
also in mice injected with INV cells. The number of metastatic
sites was 2 to 3 fold higher in the INV group than in the REF
group of mice (Fig. 3C). INV cell-injected mice died earlier than
REF cell-injected mice; only 20% of INV as compared to 80% of
the REF group survived to the end of the experiment (Fig. 3D).
Inreased growth of INV xenografts associated with
enhanced cell survival
We next explored the tumorigenicity of INV and REF cells in
nude mice. We injected REF or INV cells (2610
6) subcutaneously
Gene Symbol Gene Title Description log fold Adjusted p-value
SRPX sushi-repeat-containing
protein, X-linked
cell adhesion 0,88 0,039
FLNA filamin A, alpha (actin
binding protein 280)
actin cytoskeleton organization and biogenesis /// positive
regulation of I-kappaB kinase/NF-kappaB cascade
0,90 0,043
XIAP X-linked inhibitor of
apoptosis
apoptosis /// anti-apoptosis /// negative regulation of caspase
activity
0,91 0,040
DYNLT3 dynein, light chain,
Tctex-type 3
motor activity 0,92 0,046
TIMP1* TIMP metallopeptidase
inhibitor 1
metalloendopeptidase inhibitor activity /// positive regulation
of cell proliferation
0,97 0,039
LDOC1 leucine zipper, down-
regulated in cancer 1
negative regulation of cell proliferation 1,04 0,039
MID1 midline 1 (Opitz/BBB
syndrome)
microtubule cytoskeleton organization and biogenesis 1,04 0,039
DDX58 DEAD (Asp-Glu-Ala-Asp)
box polypeptide 58
innate immune response 1,04 0,042
CD22 CD22 molecule immune response /// cell-cell adhesion 1,05 0,039
CRLF2 cytokine receptor-like
factor 2
receptor activity 1,21 0,040
GPR87 G protein-coupled
receptor 87
G-protein coupled receptor protein signaling pathway 1,33 0,042
CSF2RA* colony stimulating factor 2
receptor, alpha, low-affinity
(granulocyte-macrophage)
hematopoietin/interferon-class (D200-domain) cytokine receptor
activity
1,38 0,039
MPP1 membrane protein,
palmitoylated 1, 55 kDa
signal transduction /// cell projection 1,43 0,011
Genes functions are based on GO Description provided by Affymetrix, NetAffx data base (https://www.affymetrix.com/analysis/netaffx/index.affx).
*Validated by QRT-PCR.
doi:10.1371/journal.pone.0023334.t002
Table 2. Cont.
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populations caused the development of 30 mm
3 tumors after one
week. After 21 days, the volumes of INV tumors were 2.6 fold
higher than those of REF tumors (172 mm
3 vs 67 mm
3,
respectively, Fig. 4A). Surprisingly, in vitro proliferation of INV
cells was half that of REF cells after 72 h of cell culture in
FCS10%/DMEM (data not shown). Thus, the faster growth of
INV tumors was unlikely to have been due to a higher
proliferation rate. We therefore evaluated cell survival within
REF and INV tumors by in situ DNA fragmentation labeling with
biotinylated nucleotides. This technique results in brown staining
of apoptotic cell nuclei and diffuse brown staining in the cytoplasm
and nuclei of necrotic cells (Fig. 4B). The numbers of dead cells
were lower in INV tumors than REF tumors (15% versus 22%,
P=0.046; Fig. 4C). In vitro after 24 h of treatment with 2.5 mM
doxorubicin (Fig. 5), 90% of REF and 59% of INV cells had
undergone apoptosis as revealed by Annexin-V labeling (Fig. 5A).
Similarly, following 96 h of serum deprivation, 40% of REF cells
and only 9.5% of INV cells were found to be apoptotic (Fig. 5B).
These various in vitro and in vivo analyses demonstrate that INV
cells are more apoptosis-resistant than REF cells. This is consistent
with the qRT-PCR and microarray evidence of up-regulation of
several anti-apoptotic molecules in INV cells including TIMP-1
([27]), TGF b2 ([28]), and IRAK1 ([29]. Also, some pro-apoptotic
molecules and some factors involved in drug-induced apoptosis
sensitization, such as cyclin D2 and caspase 4 [30], were found to
be down-regulated in INV cells. Analysis of AKT activation
showed no activation when INV as well as REF cells where in
serum free medium (Fig. 5D, lane 2, 3 and lane 5, 6) as compared
to controls stimulated with IGF-1 (lane 1 and 4).
Increased angiogenesis in INV xenografts
We next assessed angiogenesis in both INV and REF tumors
using GSL-1 lectin to labelmouse endothelial cells (Fig. 6). Both
tumor types exhibited vascular areas (Fig. 6A). The number of
endothelial cells per area was significantly higher in INV than
REF tumors (132 versus 94, respectively, p,0.05, Fig. 6B).
Analysis of genes involved in angiogenesis including those
encoding VEGF and their receptors [31–35] by qRT-PCR
revealed stronger VEGF, VEGFR2 and NRP-1 expression in
INV compared to REF cells (Fig. 6C). The over-production of
VEGF and NRP-1 proteins was confirmed by ELISA tests for
VEGF (Fig. 6D) and western blot analysis for NRP-1 (Fig. 6E).
Discussion
We report that breast cancer cell invasion through Matrigel
resulted in the generation of an aggressive subpopulation (INV)
with a stable malignant genotypic/phenotypic profile. The main
characteristic of these cells was loss of adhesion to ECM, and in
particular fibronectin and endothelial cells. Accordingly, in nude
mice, INV cells were more competent than the control cells (REF)
for extravasation through the endothelium to colonise tissues and
form metastases. Metastases formed by INV cells were mainly
Figure 2. REF and INV cell adhesion and transmigration. Morphology of INV and REF cells (A) revealed by optical microscopy at 6400
magnification. Arrows indicate cell junctions and asterisks indicate cell shape. Adhesion to fibronectin (B) and hCMEC/D3 endothelial cell adhesion
assay (C). Transmigration assays (D) involved growing hCMEC/D3 endothelial cells to confluence on the upper side of 8 mm insert Boyden chambers.
CMFDA-stained cells that transmigrated through the endothelial cells were counted as described in ‘‘Materials and Methods’’. For adhesion to
fibronectin, the data were normalized to BSA adhesion. Each column shows means (6 SD) of three independent experiments. *P,0.05.
doi:10.1371/journal.pone.0023334.g002
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5) were injected into the left ventricle of nude mice (n=7, A). Ex vivo data
confirm tissue metastasis from INV (right panel) and REF cells injection (left panel) (B). Quantification of metastatic sites (C). Mouse survival following
injection of REF and INV cells (D). Each column shows means (6SD) of representative experiments. *P versus control,0.05.
doi:10.1371/journal.pone.0023334.g003
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compared to REF ones (Exclusively in bones). This result was in
accordance with previous work of Jenkins et al [36] which
demonstrated that dissemination in other sites revealed a hallmark
of increased metastatic potential. This indicates that the ECM is
sufficient to influence the enrichment of a stable metastatic
subpopulation. We also found that INV cells failed to induce
significant platelet adhesion and/or aggregation (data not shown),
a process previously reported to be involved in metastasis processes
[37]. Previously, cell migration was reported to result from a
balance between cell adhesion and de-adhesion, both acquired for
motility. Indeed, strong adhesion would tightly attach cancer cells
to the substrate and prevent their movement. Reduced cell
adhesion to both ECM and endothelial cells, observed for our INV
subpopulation, is consistent with their enhanced migration ability,
and their capacity to cross the endothelial barrier to invade
secondary organs and form metastases. Thus, we found that the
cells obtained by transmigration through an extracellular matrix
displayed a loss of adhesion behavior. Studies on breast cancer
progression indicate that loss of cadherin or cell polarity and the
acquisition of a mesenchymal phenotype are associated with an
increase in invasiveness [38]. Accordingly, our INV cells, the
invasive subpopulation, had a fusiform shape with large spaces
between cells and thus resembled mesenchymal cells. Also, we
found weak expression of OCLN and strong expression of TGFb2,
an association which was previously demonstrated to be linked to
the breast cancer epithelial mesenchymal transition (EMT) [39].
Thus, our results support the notion that the basement membrane
may also contribute to the EMT leading to plasticity of metastatic
cells.
Using GSEA MsigDB [40] data bases, we found that the
functions of 38% of down-regulated and 47% of up-regulated
genes in INV are known (see also Fig. S1). Most are involved in the
immune/inflammatory response, cell cycle (M phase), adhesion
and dorsal root ganglion. Accordingly, 44% of the known down-
regulated genes in INV cells are involved in adhesion and cell-cell
junction (FERMT3, GABRA3, OCLN, AMIGO2, SCARF1, ASAM,
PCDHB2).
Many (25%) of the genes more strongly expressed in INV than
REF cells, are linked to cell survival by negative regulation of
Figure 4. REF and INV tumor growth. INV and REF cells were injected subcutaneously near mammary gland into nude mice as described in
‘‘Materials and Methods’’. After 1 week, tumors appeared in each group (A). Each point represents the mean tumor volume (mm
3)( 6 SD, n=7). Dead
cells in REF and INV tumor sections were stained (B). Arrows indicate apoptotic and necrotic cells (magnification6200). Percentage of cell death was
determined as described in ‘‘Materials and Methods’’ (C).
doi:10.1371/journal.pone.0023334.g004
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(VEGF) and its receptor NRP-1, both involved in the autocrine
survival of cells and microvessel permeability, processes required
for cell extravasation [41]. Other genes including IRAK1, NKAP,
FLNA, XIAP and TGFß2 were also up-regulated: XIAP and TGFb2
are associated with the NFKB pathways possibly being pivotal
potential signaling targets [42,43]. To note, also the implication of
UPA, UPAR and PAR-I in the NFKB pathway and that acted in
concert with MMP-9 to enhance INV cell invasion. Thus, further
studies on the NFKB signaling in these cell would seem interesting
to undergo. Some pro-apoptotic genes were down-regulated in
INV cells. However, important pro-apoptotic gene as for example,
BCL2 was not found to be upregulated, (Fig. S2). These include
rather CASP4 and cyclin D2, previously reported to be involved in
genistein and doxorubicin sensitization, respectively [44,30]. The
down-regulation of cyclin D2 in INV cells suggests neosis, an
important process that mediates tumor cell resistance to apoptosis,
heterogeneity and continuity [45]. These findings are in
agreement with reports of the critical role of survival during the
metastatic process of tumor cells [46]. Further, AKT analysis
showed no differences between the INV and REF cells, suggesting
that several survival genes mentioned above acted in concert to
increase resistance to death. Interestingly, in vivo, we only observed
small differences in cell death between INV cell-derived tumors
and REF tumors, suggesting that the observed difference in tumor
volumes might result from a dormancy exit. Indeed, several
reports reveal the participation of angiogenesis in the exit from
dormancy by inhibiting apoptosis [47]. The in vitro identification of
anti-apoptotic or survival targets in this work constitutes an
interesting and original finding that could lead to better treat
aggressive sub populations. In particular, it could be a good
strategy to prevent cancer relapse and to better investigate tumor
Figure 5. REF and INV cell death. Cells (2610
5) were cultured for 96 h in serum-free medium or were incubated with 2.5 mM Doxorubicin for 72 h
in a serum-containing medium (A) or were cultured for 96 h in serum-free medium (B). For qRT-PCR analysis (C), total RNA (1 mg) was reverse-
transcribed and the results were normalized as described above. (D) REF cells (Lanes 1 to 3) and INV cells (lanes 4 to 6) were treated (lane 1 and 4)
with Serum free DMEM for 1 h or for 3 days (lanes 2 and 5) or with 10 ng/ml of IGF-1 (lanes 3 and 6), to detected AKT and pAKT by western blotting.
Each column shows means (6 SD) of three independent experiments. *P,0.05.
doi:10.1371/journal.pone.0023334.g005
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first results, further investigation should address preclinal models
to indentify targets in order to treat and also survey long-term
cancer survivors minimizing the risk of cancer recurrence.
Conclusions
We demonstrated that using only basement membrane extracel-
lular matrix it is possible to obtain a stable metastatic population
without using expensive and longer in vivo procedures. Our results
suggest that future strategies for anti-metastatic therapies should
targetmoleculesinvolvedinangiogenesis and survivalratherthanin
cell adhesion. We report here the genetic, phenotypic and
functional characterization of invasive (INV) cancer cell population.
We believe that such cells will provide unique cellular models for in
vitro screening of anti-metastatic drugs with clinical potential.
Supporting Information
Figure S1 Gene expression analysis of REF and INV
cells. Down-regulated genes (A) and up-regulated genes (B) were
determined using Affymetrix Human Gene 1.0ST arrays as
described in ‘‘Materials and Methods’’.
(TIF)
Figure S2 BCL2 mRNA quantification in REF and INV
cells. Total RNA (1 mg) was reverse-transcribed using MMLV
RT and subjected to qRT-PCR as described in Material and
Methods.
(TIF)
Table S1 Complete list of genes that are down- and up-
regulated in INV cells relative to REF cells. Gene functions
are taken from the GO Description provided by NetAffx
TM
Figure 6. REF and INV tumor angiogenesis. Endothelial cells in REF and INV tumor sections were stained as described in ‘‘Materials and
Methods’’. Microvessels are revealed by brown staining (magnification6100) and endothelial cells were quantified (B). QRT-PCR was used to quantify
VEGF, VEGFR2, VEGFR1 and NRP-1 gene expression in INV and REF cells (C). VEGF (D) and NRP-1 (E) proteins were detected by ELISA tests and by
western blotting, respectively. Each column represents a mean (6 SD) of three independent experiments. *P,0.05. Gene functions from the GO
Description provided by NetAffx
TM Analysis Center Affymetrix (https://www.affymetrix.com/analysis/netaffx/index.affx)* Validated by QRT-PCR.
doi:10.1371/journal.pone.0023334.g006
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netaffx/index.affx). * Validated by qRT-PCR.
(DOC)
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